131 related articles for article (PubMed ID: 38463149)
1. Primary Non-Function of Hepatic Allograft With Preexisting Microvesicular Steatosis/Foamy Degeneration and Mild Large-Droplet Macrovesicular Steatosis.
Limia ME; Liu XL; Yu J; Byrnes K
Gastroenterology Res; 2024 Feb; 17(1):37-40. PubMed ID: 38463149
[TBL] [Abstract][Full Text] [Related]
2. Use of livers with microvesicular fat safely expands the donor pool.
Fishbein TM; Fiel MI; Emre S; Cubukcu O; Guy SR; Schwartz ME; Miller CM; Sheiner PA
Transplantation; 1997 Jul; 64(2):248-51. PubMed ID: 9256182
[TBL] [Abstract][Full Text] [Related]
3. Donor Liver Small Droplet Macrovesicular Steatosis Is Associated With Increased Risk for Recipient Allograft Rejection.
Choi WT; Jen KY; Wang D; Tavakol M; Roberts JP; Gill RM
Am J Surg Pathol; 2017 Mar; 41(3):365-373. PubMed ID: 28059835
[TBL] [Abstract][Full Text] [Related]
4. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers.
Yersiz H; Lee C; Kaldas FM; Hong JC; Rana A; Schnickel GT; Wertheim JA; Zarrinpar A; Agopian VG; Gornbein J; Naini BV; Lassman CR; Busuttil RW; Petrowsky H
Liver Transpl; 2013 Apr; 19(4):437-49. PubMed ID: 23408461
[TBL] [Abstract][Full Text] [Related]
5. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.
de Graaf EL; Kench J; Dilworth P; Shackel NA; Strasser SI; Joseph D; Pleass H; Crawford M; McCaughan GW; Verran DJ
J Gastroenterol Hepatol; 2012 Mar; 27(3):540-6. PubMed ID: 21777274
[TBL] [Abstract][Full Text] [Related]
6. Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients.
Ferri F; Lai Q; Molinaro A; Poli E; Parlati L; Lattanzi B; Mennini G; Melandro F; Pugliese F; Maldarelli F; Corsi A; Riminucci M; Merli M; Rossi M; Ginanni Corradini S
Can J Gastroenterol Hepatol; 2019; 2019():5862985. PubMed ID: 31187028
[TBL] [Abstract][Full Text] [Related]
7. The Propensity of the Human Liver to Form Large Lipid Droplets Is Associated with PNPLA3 Polymorphism, Reduced INSIG1 and NPC1L1 Expression and Increased Fibrogenetic Capacity.
Ferri F; Carotti S; Carpino G; Mischitelli M; Cantafora A; Molinaro A; Argenziano ME; Parisse S; Corsi A; Riminucci M; Lai Q; Mennini G; Spadetta G; Pugliese F; Rossi M; Morini S; Gaudio E; Ginanni Corradini S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198853
[TBL] [Abstract][Full Text] [Related]
8. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
[TBL] [Abstract][Full Text] [Related]
9. Frozen section diagnosis in donor liver biopsies: observer variation of semiquantitative and quantitative steatosis assessment.
Biesterfeld S; Knapp J; Bittinger F; Götte H; Schramm M; Otto G
Virchows Arch; 2012 Aug; 461(2):177-83. PubMed ID: 22772768
[TBL] [Abstract][Full Text] [Related]
10. Automated image analysis method for detecting and quantifying macrovesicular steatosis in hematoxylin and eosin-stained histology images of human livers.
Nativ NI; Chen AI; Yarmush G; Henry SD; Lefkowitch JH; Klein KM; Maguire TJ; Schloss R; Guarrera JV; Berthiaume F; Yarmush ML
Liver Transpl; 2014 Feb; 20(2):228-36. PubMed ID: 24339411
[TBL] [Abstract][Full Text] [Related]
11. Frozen section evaluation of donor livers before transplantation.
Markin RS; Wisecarver JL; Radio SJ; Stratta RJ; Langnas AN; Hirst K; Shaw BW
Transplantation; 1993 Dec; 56(6):1403-9. PubMed ID: 7506453
[TBL] [Abstract][Full Text] [Related]
12. Gamma-glutamyltransferase predicts macrovesicular liver graft steatosis - an analysis of discarded liver allografts in Finland.
Savikko J; Åberg F; Tukiainen E; Nordin A; Mäkisalo H; Arola J; Isoniemi H
Scand J Gastroenterol; 2023 Apr; 58(4):412-416. PubMed ID: 36308000
[TBL] [Abstract][Full Text] [Related]
13. Combined Effect of Deceased Donor Macrovesicular and Microvesicular Steatosis on Liver Transplantation Outcomes: Analysis of SRTR Data Between 2010 and 2018.
Ayloo S; Molinari M; Pentakota SR
Transplant Proc; 2021 Dec; 53(10):2971-2982. PubMed ID: 34740448
[TBL] [Abstract][Full Text] [Related]
14. Quantification of macrovesicular and microvesicular hepatic steatosis in rats using 3.0-T ¹H-magnetic resonance spectroscopy.
Ou HY; Chao PH; Yu PC; Wei YC; Chen CL; Yu CY; Chiu TM; Chang YC; Lai CY; Cheng YF
Transplant Proc; 2012 May; 44(4):955-8. PubMed ID: 22564595
[TBL] [Abstract][Full Text] [Related]
15. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.
Limanond P; Raman SS; Lassman C; Sayre J; Ghobrial RM; Busuttil RW; Saab S; Lu DS
Radiology; 2004 Jan; 230(1):276-80. PubMed ID: 14695401
[TBL] [Abstract][Full Text] [Related]
16. Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation.
Andert A; Ulmer TF; Schöning W; Kroy D; Hein M; Alizai PH; Heidenhain C; Neumann U; Schmeding M
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):617-623. PubMed ID: 29291781
[TBL] [Abstract][Full Text] [Related]
17. Micro- and macrovesicular steatotic liver model for transplantation induced by ethanol and protein-deficient diet.
Spannbauer MM; Oleszczuk A; Tannapfel A; Blüher M; Pietsch UC; Hengstler J; Donaubauer B; Madaj-Sterba P; Fürll M; Schuhmacher A; Thiery J; Hauss JP; Schön MR
Transplant Proc; 2005; 37(1):210-1. PubMed ID: 15808596
[TBL] [Abstract][Full Text] [Related]
18. Influence of donor post-reperfusion changes on graft evolution after liver transplant.
Busquets J; Serrano T; Figueras J; Ramos E; Torras J; Rafecas A; Fabregat J; Xiol X; Lama C; Ibáñez L; Jaurrieta E
Rev Esp Enferm Dig; 2001 Jan; 93(1):39-47. PubMed ID: 11488096
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of hepatocellular carcinoma with fatty change: Tumors with macrovesicular steatosis have better prognosis and aberrant expression patterns of perilipin and adipophilin.
Kubota N; Ojima H; Hatano M; Yamazaki K; Masugi Y; Tsujikawa H; Fujii-Nishimura Y; Ueno A; Kurebayashi Y; Shinoda M; Kitago M; Abe Y; Kitagawa Y; Sakamoto M
Pathol Int; 2020 Apr; 70(4):199-209. PubMed ID: 31930673
[TBL] [Abstract][Full Text] [Related]
20. Effect of Donor Hepatic Steatosis on Ischemia Reperfusion Injury in Liver Transplant Recipient.
Jadhav PV; Kothakota SR; Sasidharan M; Kareem H; Nair AK
J Clin Exp Hepatol; 2020; 10(3):236-244. PubMed ID: 32405180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
